Loading clinical trials...
Loading clinical trials...
A Multi-Center Randomized-Controlled Trial To Evaluate The Safety And Feasibility of The Delivery Of Intracoronary Hyperoxemic Supersaturated Oxygen Therapy For 60 Minutes In Patients With St Elevation Myocardial Infarction (STEMI) And Cardiogenic Shock After Successful Reperfusion (Via PCI) ≤ Six Hours After Symptom Onset Compared To Standard Therapy
Conditions
Interventions
SSO2 Downstream System
PCI + Impella
Locations
7
United States
Baptist Health South Florida
Miami, Florida, United States
Baystate Medical Center
Springfield, Massachusetts, United States
Henry Ford Health System
Detroit, Michigan, United States
WakeMed
Raleigh, North Carolina, United States
Lehigh Valley Hospital-Cedar Crest
Allentown, Pennsylvania, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Start Date
December 17, 2021
Primary Completion Date
January 17, 2024
Completion Date
June 1, 2025
Last Updated
January 24, 2024
NCT06647069
NCT07015983
NCT07371468
NCT04419480
NCT06561048
NCT07438496
Lead Sponsor
TherOx
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions